Gilead Receives Complete Response Letter From U.S. FDA for Investigational Lenacapavir Due to Vial Compatability Issues Pharmaceutical Investing
Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite Patient Enrollment in the LANCER Trial Pharmaceutical Investing
BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference Pharmaceutical Investing
Salix and Colon Cancer Coalition Join Forces for 'Faces of Blue' Story Series to Raise Awareness of Colorectal Cancer Screenings Pharmaceutical Investing
Phase 3 CLOVER Trial for Pfizer's Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints Life Science Investing
Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease Pharmaceutical Investing
Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders Pharmaceutical Investing
AbbVie Provides Update Regarding SKYRIZI® for the Treatment of Moderate to Severe Crohn's Disease in the U.S. Pharmaceutical Investing
AbbVie Seeks New Indication for IMBRUVICA® in Pediatric Patients with Chronic Graft Versus Host Disease Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
